- Report
- June 2025
- 145 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- March 2025
- 139 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- August 2025
- 262 Pages
Global
From €3413EUR$3,825USD£3,009GBP
€4015EUR$4,500USD£3,540GBP
- Report
- March 2025
- 185 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- February 2025
- 184 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- January 2025
- 182 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- November 2024
- 183 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- October 2025
- 182 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 196 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 182 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 182 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 187 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 191 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 194 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 192 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 199 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 188 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- August 2025
- 194 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- April 2025
- 200 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- November 2025
- 215 Pages
Global
From €5220EUR$5,850USD£4,603GBP

Single Nucleotide Polymorphism (SNP) is a type of genetic variation that occurs when a single nucleotide in the genome sequence is altered. SNPs are the most common type of genetic variation among individuals and are used in genomics to identify genetic differences between individuals. SNP analysis is used to identify genetic markers associated with diseases, to study the genetic basis of complex traits, and to identify genetic variants associated with drug response.
SNP analysis is used in a variety of applications, including personalized medicine, pharmacogenomics, and population genetics. SNP analysis is also used in the development of diagnostic tests, drug discovery, and gene therapy. SNP analysis is also used in the development of genetic tests for disease risk assessment and in the development of genetic tests for disease diagnosis.
The SNP market is a rapidly growing market, driven by the increasing demand for personalized medicine and the development of new technologies for SNP analysis. Companies in the SNP market include Illumina, Thermo Fisher Scientific, BGI, and Genomics plc. Show Less Read more